Do Analysts Expect Rubius Therapeutics Inc (RUBY) Stock to Rise After It Has Gained 11.76% in a Month?
Friday, January 06, 2023 12:33 PM | InvestorsObserver Analysts
Mentioned in this article
Wall Street is positive on Rubius Therapeutics Inc (RUBY). On average, analysts give RUBY a Hold rating. The average price target is $5, which means analysts expect the stock to rise by 2531.58% over the next twelve months.
That average ranking earns RUBY an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating RUBY a Hold today. Find out what this means to you and get the rest of the rankings on RUBY!
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Rubius Therapeutics Inc Stock Today?
Rubius Therapeutics Inc (RUBY) stock is lower by -12.5% while the S&P 500 has risen 1.63% as of 12:26 PM on Friday, Jan 6. RUBY is lower by -$0.03 from the previous closing price of $0.21 on volume of 1,435,014 shares. Over the past year the S&P 500 has fallen -17.59% while RUBY is lower by -98.03%. RUBY lost -$2.38 per share the over the last 12 months.
Click Here to get the full Stock Report for Rubius Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter